Use of DTIC in the malignant carcinoid syndrome. [Cancer Treat Rep. 1977 Jan-Feb] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Cancer Treat Rep. 1977 Jan-Feb;61(1):101-2.Links

Use of DTIC in the malignant carcinoid syndrome.

Kessinger A, Foley JF, Lemon HM.

PMID: 861955 [PubMed - indexed for MEDLINE]

Related Articles

Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine. [Cancer Treat Rep. 1976]
ReviewDTIC (NSC-45388) in malignant melanoma: a perspective. [Cancer Treat Rep. 1976]
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma. [Med Pediatr Oncol. 1975]
Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion. [Am J Surg. 1974]
ReviewChemotherapy of metastatic carcinoid and islet cell tumors. A review. [Am J Med. 1987]

|

Patient Drug Information

Dacarbazine (DTIC-Dome®) Your doctor has ordered the drug dacarbazine to help treat your illness. The drug is given by injection into a vein.

» read more ...

Display Show